APA (7th ed.) Citation

Roeten, M. S. F., Meerloo, J. v., Dijk, S. N. v., Kwidama, Z., Jenkins, G., Teachey, D. T., . . . Cloos, J. High immunoproteasome and low constitutive proteasome subunit levels correlate with sensitivity to bortezomib-containing chemotherapy: Update from the Children’s Oncology Group AALL1231 trial. Ferrata Storti Foundation.

Chicago Style (17th ed.) Citation

Roeten, Margot S. F., et al. High Immunoproteasome and Low Constitutive Proteasome Subunit Levels Correlate with Sensitivity to Bortezomib-containing Chemotherapy: Update from the Children’s Oncology Group AALL1231 Trial. Ferrata Storti Foundation.

MLA (9th ed.) Citation

Roeten, Margot S. F., et al. High Immunoproteasome and Low Constitutive Proteasome Subunit Levels Correlate with Sensitivity to Bortezomib-containing Chemotherapy: Update from the Children’s Oncology Group AALL1231 Trial. Ferrata Storti Foundation.